Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors.
Kim TM, Lee KW, Oh DY, Lee JS, Im SA, Kim DW, Han SW, Kim YJ, Kim TY, Kim JH, Han H, Kim WH, Bang YJ.
Kim TM, et al. Among authors: han h, han sw.
Cancer Res Treat. 2018 Jul;50(3):835-842. doi: 10.4143/crt.2017.303. Epub 2017 Aug 29.
Cancer Res Treat. 2018.
PMID: 28859471
Free PMC article.
Clinical Trial.